House Amendment 1
S 407 - Session 125 (2023-2024)
Narcan OTC

The Committee on Medical, Military, Public and Municipal Affairs proposes the following amendment (LC-407.WAB0005H):

Amend the bill, as and if amended, SECTION 1, Section 44-53-361(A), by adding an item to read:

  (1) This subsection does not apply in the following circumstances:

   (a)patients who are receiving care for cancer or a cancer-related condition, patients in hospice, patients receiving palliative care; or 

   (b)any other patients who, in the prescriber's good faith medical judgment, would not benefit from a prescription for naloxone hydrochloride or another drug approved by the United States Food and Drug Administration for the complete or partial reversal of opioid-related respiratory and/or central nervous system depression.